Bibliografia

• Abramowicz A. Baclofen (Lioresal). Med Lett Drugs Therapy 1975; 20: 43-7.
• Avellino A, Loeser JD. Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology. Neuromodulation 2000; 3(2): 75-81.
• Becker R, Alberti O, Bauer B. Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol 1997; 244: 160-6.
• Bowery N, Doble A, Hill D, et al. Bicuculline-insensitive GABA receptors on peripheral autonomic nerve terminals. Eur J Pharmacol 1981; 71: 53-70.
• Bowery N, Hill D, Hudson A. [3H](-)Baclofen: an improved ligand for GABAB sites. Neuropharmacology 1985; 24: 207-10.
• Capek R, Esplin B. Baclofen-induced decrease of excitability of primary afferents and depression of monosynaptic transmission in cat spinal cord. Can J Physiol Pharmacol 1982; 60: 160-6.
• Chua K, Chuo A, Kong K. Urinary incontinence after traumatic brain injury: incidence, outcomes and correlates. Brain Inj 2003; 17: 469-78.
• Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 2004; 27(11): 799-818.
• De Groat W. The actions of gamma-aminobutyric acid and related amino acids on mammalian autonomic ganglia. J Pharmacol Exp Ther 1970; 172: 384-6.
• De Groat W, Booth A, Yoshimura N. Neurophysiology of micturition and its modification in animal models of human disease. In: CA Maggi (ed). The autonomic nervous system. Nervous control of the urogenital system. London: Harwood Academic, 1993.
• De Groat W, Nadelhaft I, Milne R, et al. Organization of the sacral parasympathetic reflex pathway to the urinary bladder and large intestine. J Auton Nerv System 1981; 4: 135-60.
• Dvorak E, Ketchum N, McGuire J. The underutilization of intrathecal baclofen in poststroke spasticity. Top Stroke Rehabil 2011; 18(3): 195-202.
• Elovic E. Principles of pharmaceutical management of spastic hypertonia. Phys Med Rehabil Clin N Am 2001; 12: 793-816.
• Giannantoni A, Silvestro D, Siracusano S, et al. Urologic dysfunction and neurologic outcome in coma survivors after severe traumatic brain injury in the postacute and chronic phase. Arch Phys Med Rehabil 2011; 92(7): 1134-8.
• Griffiths D, Holstege G, Dalm E, et al. Control and coordination of bladder and urethral function in the brainstem of the cat. Neurourol Urodyn 1990; 9: 63-82.
• Igawa Y, Mattiasson A, Andersson K. Effect of GABA-receptor stimulation and baclofen on micturition in normal rats with bladder outflow obstruction. J Urol  1993; 150: 537-42.
• Ito T, Furukawa K, Karasawa T, et al. Effects of chlorpromazine, imipramine and baclofen on the spinal polysynaptic reflex in acute, chronic and 6-hydroxydopamine treated spinal rats. Jpn J Pharmacol 1982; 32: 1125-33.
• Jessen R, Mirsky R, Dennison M, et al. GABA may be a neurotransmitter in the vertebrate peripheral nervous system. Nature (London) 1979; 281: 71-4.
• Katz R. Management of spasticity. Am J Phys Med Rehabil 1988; 67:108-16.
• Kofler M, Matzak H, Saltuari L. The impact of intrathecal baclofen on gastrointestinal function. Brain Inj 2002;16(9): 825-36.
• Kontani H, Kawabata Y, Koshiura R. In vivo effects of γ-aminobutyric acid on the urinary bladder contraction accompanying micturition. Jpn J Pharmacol 1987; 45: 45-53.
• Kontani H, Kawabata Y, Koshiura R. The effect of baclofen on the urinary bladder contraction accompanying micturition in anesthetized rats. Jpn J Pharmacol 1988; 46: 7-15.
• Kontani H, Nakagawa M, Sakai T. Effects of central nervous system-acting drugs on urinary bladder contraction in unanesthetized rats. Jpn J Pharmacol 1989; 50: 327-32.
• Krimchansky B, Sazbon L, Heller L, et al. Bladder tone in post-traumatic vegetative state. Brain Inj 1999; 13: 899-903.
• Kwah L, Harvey L, Diag J et al. Half of adults who present to hospital with stroke develop at least one contracture within 6 months: an observational study. J Physiother 2012; 58: 41-7.
• Lundström E, Terent A, Borg J. Prevalence of disabling spasticity 1 year after first-ever stroke. Eur J Neurol 2008; 15: 533-9.
• Maggi C, Furio M, Santicioli P, et al. The spinal and supraspinal components of GABAergic inhibition of micturition reflex in rats. J Pharmacol Exp Ther 1987; 240: 998-1000.
• Maggi C, Santicioli P, Giuliani S, et al. The effects of baclofen on spinal and supraspinal micturition reflexes in rats. Naunyn Schmiedebergs Arch Pharmacol 1987; 336: 197-203.
• Maggi C, Santicioli P, Meli A. Somatovesical and vesicovesical excitatory reflexes in urethane-anaesthetized rats. Brain Res 1986; 380: 83-93.
• Maggi C, Santicioli P, Meli A. Sympathetic inhibition of reflex activation of bladder motility during filling at a physiological-like rate in urethane-anaesthetized rats. Neurourol Urodyn 1985; 4: 37-45.
• Mallory B, Roppolo J, de Groat W. Pharmacological modulation of the pontine micturition center. Brain Res 1991; 546: 310-20.
• Meythaler J, Clayton W, Davis L, et al. Orally delivered baclofen to control spastic hypertonia in acquired brain injury. J Head Trauma Rehabil 2004; 19(2): 101-8.
• Meythaler J, DeVivo M, Hadley M. Prospective study on the use of bolus ntrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil 1996; 77: 461-6.
• Meythaler J, Guin-Renfroe S, Brunner R, et al. Intrathecal baclofen for spastic hypertonia from stroke. Stroke 2001; 32: 2099-109.
• Moiyadi A, Indira Devi B, Sivaraman Nair K. Urinary disturbances following traumatic brain injury. Clinical and urodynamic evaluation. Neurorehabilitation 2007; 22: 93-8.
• Morant A, Noé E, Boyer J, et al. Paralytic ileus: a complication after intrathecal baclofen therapy. Brain Inj 2006; 20: 1451-4.
• Morikawa K, Hashimoto S, Yamauchi T, et al. Inhibitory effect of inaperisone hydrochloride (inaperisone), a new centrally acting muscle relaxant, on the micturition reflex. Eur J Pharmacol 1992; 213: 409-15.
• Morikawa K, Ichihashi M, Kakiuchi M, et al. Effects of various drugs on bladder function in conscious rats. Jpn J Pharmacol 1989; 50: 369-76.
• Morikawa K, Kakiuchi M, Yamauchi T, et al. Pharmacological studies on the micturition reflex (2): effects of various drugs on bladder and urethral functions in rats and dogs. Pharmacometrics 1989; 37: 27-37.
• Murphy MP, Carmine H. Long-term health implications of individuals with TBI: A rehabilitation perspective. NeuroRehabilitation 2012; 31(1): 1-12.
• Nanninga J, Frost F, Penn R. Effect of intrathecal baclofen on bladder and sphincter function. J Urol 1989; 142: 101-5.
• Natale M, Mirone G, Rotondo M, et al. Intrathecal baclofen therapy for severe spasticity: analysis on a series of 112 consecutive patients and future prospectives. Clin Neurol Neurosurg 2012; 114(4): 321-5.
• Nuttin B, Ivanhoe C, Albright L, et al. Intrathecal baclofen therapy for spasticity of cerebral origin: cerebral palsy and brain injury. Neuromodulation 1999; 2(2): 120-32.
• Oostra K, Everaer K, Van Laere M. Urinary incontinence in brain injury. Brain Inj 1996; 10: 459-64.
• Ordia J, Fischer E, Adamski E, et al. Chronic intrathecal delivery of baclofen by a programmable pump for the treatment of severe spasticity. J Neurosurg 1996; 85: 452-7.
• Patti F, Pappalardo A, Lo Fermo S, et al. Life-threatening constipation induced by intrathecal baclofen therapy. Eur Neurol 2008; 60(2): 95-6.
• Pistoia F, Sacco S, Sarà M et al. Intrathecal baclofen: effects on spasticity, pain, and consciousness in disorders of consciousness and locked-in syndrome. Curr Pain Headache Rep 2015; 19(1): 466-73.
• Posteraro F, Calandriello B, Galli R, et al. Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome. Brain Inj 2013; 27: 1671-5.
• Rifici C, Kofler M, Kronenberg M, et al. Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol 1994; 9(1): 29-34.
• Saltuari L, Frischhut B. Treatment concepts of tertiary damage of the locomotor system after craniocerebral trauma. Orthopade 1992; 21(5): 339-45.
• Saltuari L, Kronenberg M, Marosi M, et al. Long-term intrathecal baclofen treatment in supraspinal 
spasticity. Acta Neurol 1992; 47:195-207.
• Saltuari L, Schmutzhard E, Kofler M, et al. Intrathecal baclofen for intractable spasticity due to severe brain injury. Lancet 1989; 2(8661): 503-4.
• Sarà M, Pistoia F, Mura E, et al. Intrathecal baclofen in patients with persistent vegetative state: 2 hypotheses. Arch Phys Med Rehabil 2009; 90(7): 1245-9.
• Sarà M, Sacco S, Cipolla F, et al. An unexpected recovery from permanent vegetative state. Brain Inj 2007; 21(1):101-3.
• Schutter N, Verhaar H, Ottervanger J. Intestinal pseudo-obstruction during use of baclofen. Ned Tijdschr Geneeskd 1995; 139: 1891-3.
• Sillen U, Persson B, Rubenson A. Central effects of baclofen on the L-DOPA induced hyperactive urinary bladder of the rat. Naunyn Schmiedebergs Arch Pharmacol 1985; 330: 175-8.
• Steers W, Meythaler J, Haworth C, et al. Effects of acute bolus 
and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology. J Urol 1992; 148: 1849-55.
• Taira T, Hori T. Intrathecal baclofen in the treatment of post stroke central pain, dystonia, and persistent vegetative state. Acta Neurochir Suppl 2007; 97: 227-9.
• Taniyama K, Kusunoki M, Saito N, et al. Release of gamma-a minobutyric from cat colon. Science 1982; 217: 1038-40.
• Wedekind C, Lippert-Grüner M. Long-term outcome in severe traumatic brain injury is significantly influenced by brainstem involvement. Brain Inj 2005; 19(9): 681-4.
• Wein A Applied pharmacology. In: Stanton SL (ed) Clinical gynecologic urology. St. Louis Toronto: Mosby Co, 1984.
• Wyndaele J. Urodynamics in comatose patients. Neurourol Urodyn 1990; 9: 43-52.